§ BIOTECHNOLOGY
USD · BiotechnologyTARA
PROTARA THERAPEUTIC INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
77 increased/new, 33 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.2M | n/a | +1% |
| BlackRock, Inc. | 3.4M | 0.0% | +41% |
| Velan Capital Investment Management LP | 2.8M | 9.3% | ±0% |
| Millennium Management | 2.8M | 0.0% | +276% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | n/a | n/a |
| Sio Capital Management, LLC | 2.0M | 1.5% | +15% |
◇ AC INTELLIGENCE
Top institutional owners for TARA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER50.7% · 72 holders
QUALITY / COMPOUNDER20.6% · 6 holders
DEALER / BANK9.7% · 18 holders
PASSIVE / INDEX8.9% · 7 holders
TACTICAL / MACRO7.5% · 2 holders
SYSTEMATIC / QUANT1.5% · 4 holders
INCOME / DEFENSIVE0.3% · 5 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for TARA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention TARA yet.